NEW VISITOR POLICY in effect as of Monday, March 30
See all Novel Coronavirus Information for Penn Medicine Patients
Due to the recent Novel Coronavirus emergency, some locations may be operating with different hours or temporarily closed.
Prostate cancer is the second most common cancer among American men. Fortunately, survival rates are excellent, and new less invasive surgery and advanced treatment options offer enhanced quality of life.
Our approach includes minimally invasive surgical techniques and advanced treatment options to treat the cancer while addressing quality of life concerns such as urinary incontinence and sexual impotency.
Prostate cancer affects one in every six men in the U.S. Roughly 90% of all prostate cancers are detected in the early stages when tumors are confined within the prostate, making the cure rate promising. Some prostate cancers are more aggressive than others. If those aggressive tumors are untreated and allowed to grow, they can spread to other parts of the body, causing the cure rate to drop dramatically.
Talk with your doctor to see whether a prostate-specific antigen blood test (PSA) is recommended for early detection of prostate cancer.
Treatment options for prostate cancer include surgery, radiation therapy using advanced technology, clinical trials, immunotherapy and hormonal therapy.
No matter what kind of cancer you are facing, we will help guide you through your journey, providing the best possible information, care and support.
Our support services include a wide range of programs, education and events to help cancer patients and their loved ones.
Find our contact forms and phone numbers or give feedback on a recent experience using Care to Share.
View test results, schedule appointments, or request prescription refills from the convenience of your computer or mobile device.
Learn about health system news and meet new providers in Progress Notes, Lancaster General Health's provider newsletter.